Jerry L Spivak MD, MACPProfessor of Medicine and Oncology, Director, the Johns Hopkins Center for the Chronic Myeloproliferative Disorders, Johns Hopkins Medical Institution, Baltimore, MD
Jerry L. Spivak, MD, MACP, is a Professor of Medicine and Oncology at the Johns Hopkins University School of Medicine and a member of the active staff of the Johns Hopkins Hospital. Dr. Spivak is a graduate of Cornell University Medical College and received training in internal medicine, hematology and oncology at the Johns Hopkins Hospital, New York Hospital and the National Cancer Institute. Board certified in Internal Medicine and Hematology, Dr. Spivak was Director of the Hematology Division at Johns Hopkins from 1980 to 1992. He is currently the Director of the Johns Hopkins Center for The Chronic
Myeloproliferative Disorders. An author of 266 clinical and scientific publications, the recipient of a Research Career Development Award and a Merit Award from the National Institutes of Health, Dr. Spivak’s research and clinical interests involve the pathogenesis, diagnosis and management of the chronic myeloproliferative disorders, polycythemia vera, primary myelofibrosis, essential thrombocytosis, and, in particular, hematopoietic stem cell behavior in these disorders. His laboratory has expertise in the areas of cell biology, protein chemistry and molecular biology with a special focus on mouse and human hematopoietic stem cell behavior in vitro and in vivo using animal models as surrogates for human disease.